ITFG2-AS1

Across TCGA pan-cancer cohorts, ITFG2-AS1 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated ITFG2-AS1 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher ITFG2-AS1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated ITFG2-AS1 expression acts as an unfavorable survival marker, although some lineages such as READ and UVM show a favorable association.

READ, UVM, and OV are the cancer types where ITFG2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	All	0.839	0.583	<.001	110	view →
UVM	OS	Median	All	0.769	0.368	<.001	55	view →
OV	DFS	Median	IV	0.400	0.211	.005	36	view →
UCS	DFS	Quartile	II,III,IV	0.684	0.238	.011	30	view →
COAD	DFS	Quartile	III,IV	0.526	0.783	.006	30	view →
THYM	DFS	Tertile	All	1.000	0.722	.007	24	view →
HNSC	OS	Median	IV	0.670	0.537	.009	20	view →
LUAD	OS	Quartile	II,III,IV	0.421	0.234	.011	14	view →
MESO	OS	Median	All	0.658	0.355	.017	13	view →
KIRC	DFS	Quartile	IV	0.301	0.596	.006	12	view →
ACC	OS	Quartile	All	0.855	0.967	.021	10	view →
CHOL	DFS	Median	III,IV	0.647	0.127	.006	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

ITFG2-AS1–READ (DFS)

Open the READ breakdown →